Key stats
About KODEX SYNTH-US BIO
Home page
Inception date
Oct 31, 2013
Replication method
Synthetic
Dividend treatment
Capitalizes
Primary advisor
Samsung Asset Management Co., Ltd.
ISIN
KR7185680006
KODEX Synth-US bio mainly focuses on USA's biotechnology companies committed to healthier future.
Classification
Returns
1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
---|---|---|---|---|---|---|
Price performance | — | — | — | — | — | — |
NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Miscellaneous
Bonds, Cash & Other100.00%
Miscellaneous93.73%
ETF5.81%
Cash0.46%
Stock breakdown by region
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
185680 assets under management is 14.32 B KRW. It's risen 7.23% over the last month.
185680 fund flows account for −3.04 B KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 185680 doesn't pay dividends to its holders.
185680 shares are issued by Samsung Life Insurance Co., Ltd. under the brand KODEX. The ETF was launched on Oct 31, 2013, and its management style is Passive.
185680 expense ratio is 0.25% meaning you'd have to pay 0.25% of your investment to help manage the fund.
185680 follows the S&P Biotechnology Select Industry. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
185680 invests in funds.
185680 price has risen by 3.05% over the last month, and its yearly performance shows a −11.39% decrease. See more dynamics on 185680 price chart.
NAV returns, another gauge of an ETF dynamics, showed a −7.71% decrease in three-month performance and has decreased by −7.07% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −7.71% decrease in three-month performance and has decreased by −7.07% in a year.
185680 trades at a premium (0.28%) meaning the ETF is trading at a higher price than the calculated NAV.